Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,608 | 10,734 | 10,479 | 11,916 | 14,067 |
| Other current assets | 91 | 155 | 184 | 288 | 12 |
| TOTAL | $9,699 | $10,889 | $10,663 | $12,204 | $14,079 |
| Non-Current Assets | |||||
| PPE Net | 122 | 139 | 156 | 173 | 190 |
| Other Non-Current Assets | 12 | 30 | 12 | 0 | 0 |
| TOTAL | $134 | $169 | $168 | $173 | $190 |
| Total Assets | $9,833 | $11,058 | $10,831 | $12,377 | $14,269 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 962 | 421 | 424 | 712 | 658 |
| Accrued Expenses | 313 | 327 | 708 | 298 | 341 |
| Other current liabilities | 12 | 10 | N/A | N/A | N/A |
| TOTAL | $1,287 | $758 | $1,132 | $1,010 | $999 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,287 | $758 | $1,132 | $1,010 | $999 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,981 | 6,896 | 6,596 | 6,596 | 6,596 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -162,012 | -159,559 | -157,399 | -154,982 | -152,391 |
| TOTAL | $8,546 | $10,300 | $9,699 | $11,367 | $13,270 |
| Total Liabilities And Equity | $9,833 | $11,058 | $10,831 | $12,377 | $14,269 |